[Retracted] E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left">Gene</td><td class="align_center">GPL1708</td><td class="align_center">GPL4133</td><td class="align_center">GPL21974</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">HOXA9</td><td class="align_center">0.5683</td><td class="align_center">0.875</td><td class="align_center">0.8529</td></tr><tr><td class="align_left">SPDEF</td><td class="align_center">0.5863</td><td class="align_center">0.6406</td><td class="align_center">0.7353</td></tr><tr><td class="align_left">FOXA1</td><td class="align_center">0.6325</td><td class="align_center">0.7813</td><td class="align_center">0.6691</td></tr><tr><td class="align_left">E2F1</td><td class="align_center">0.7437</td><td class="align_center">0.8438</td><td class="align_center">0.6176</td></tr><tr><td class="align_left">PGR</td><td class="align_center">0.6637</td><td class="align_center">0.9219</td><td class="align_center">0.5735</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>The ROC values of five TFs in each of the three datasets.</div>

Disease Markers

tab4

Table 4

Table 4: [Retracted] E2F1 Affects the Therapeutic Response to Neoadjuvant Therapy in Breast Cancer 